Cameco: Uranium Stages A Comeback, The Market Starts To Notice

Cameco: Uranium Stages A Comeback, The Market Starts To Notice

RHJ Investment Thesis

Cameco (NYSE: CCJ ) reported 12.9% of adjusted net earnings margins. Not only is this a massive improvement from Q1, but it’s a truly impressive improvement from the same period a year ago, which was marked by negative double digits in adjusted earnings margin.

That’s not to say that the sky is rosy and the outlook is sizzling strong. However, we are talking about a business that is now in a markedly different position from last year and there are reasons to conclude that Cameco’s prospects could substantially improve going forward.

I believe that paying 6x this year’s revenues is a very fair multiple for this investment. Here’s why: Revenue Growth Rates Likely to Remain Elevated, But Cameco Fails to Revise Its Outlook Upwards Cameco revenue growth rates Cameco reported Q2 2022 revenue growth rates of 55%. This was a mightily impressive result, which saw its revenue growth […]

About the author: StockMan
Tell us something about yourself.
Posting Guidelines
Do
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!

Comments

No comments yet